Floatz logo

Famotidine

Anatomic Stage 0 Breast Cancer AJCC v8

Ohio State University Comprehensive Cancer CenterSmall moleculePhase 2/3Active
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
46/ 100
Competitive Position
95/ 100

Competitive context

16 Active assets in the Anatomic Stage 0 Breast Cancer AJCC v8 cohort.

Asset / SponsorPhaseRating
EXEMESTANE
Alliance for Clinical Trials in Oncology
Phase 4BBB
Letrozole
Alliance for Clinical Trials in Oncology
Phase 4BBB
TAMOXIFEN
Alliance for Clinical Trials in Oncology
Phase 4BB
Arimidex
Alliance for Clinical Trials in Oncology
Phase 4BB
Cyclophosphamide
Roswell Park Cancer Institute
Phase 3BB

View all 29 →

Same molecule, other indications

Famotidine is also rated in:

sickle cell diseaseDormant
BB
Indicative ·
65 / 100
View asset →
ulcer diseaseDormant
BB
Indicative ·
64 / 100
View asset →
schizophreniaDormant
B
Indicative ·
63 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →